Johnson and Johnson Vision Introduces VERITAS Vision System With Features To Address Key Unmet Needs In Cataract Surgery
High-performance, next-generation cataract surgery system is now globally available and offers surgeons enhanced safety and exceptional efficiency SANTA ANA, Calif., July 23, 2021 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson Vision,* ... Devices, Ophthalmology, Product Launch Johnson & Johnson Vision, VERITAS Vision System, phacoemulsification, cataract (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 23, 2021 Category: Pharmaceuticals Source Type: news

ImaginAb Announces Extension Of Long-Standing Partnership With Boehringer Ingelheim
New license and supply agreement will see ImaginAb supply Boehringer Ingelheim with its market leading CD8 ImmunoPET technology LOS ANGELES, July 23, 2021 -- (Healthcare Sales & Marketing Network) -- ImaginAb Inc, a market leading global biotechnology ... Biopharmaceuticals, Radiology, Licensing ImaginAb, Boehringer Ingelheim, radiopharmaceuticals, ImmunoPET (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 23, 2021 Category: Pharmaceuticals Source Type: news

Hong Kong Sanatorium and Hospital Transforms Cancer Care in Asia with Treatment of First Patient Using the Accuray Radixact(R) System and ClearRT(TM) Helical Fan-Beam kVCT Imaging
ClearRT Significantly Improves Image Quality, Facilitating the Delivery of More Precise and Accurate Treatments to Patients SUNNYVALE, Calif., July 22, 2021 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (NASDAQ: ARAY) announced toda... Devices, Oncology Accuray, Radixact System, ClearRT, radiosurgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 22, 2021 Category: Pharmaceuticals Source Type: news

NuVasive Launches Modulus ALIF 3D-Printed Porous Titanium Implant for Anterior Spine Surgery
SAN DIEGO, July 22, 2021 -- (Healthcare Sales & Marketing Network) -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced t... Devices, Neurosurgery, Orthopaedic, Product Launch NuVasive, Modulus ALIF, anterior lumbar interbody fusion, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 22, 2021 Category: Pharmaceuticals Source Type: news

Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
Benny Sorensen appointed Chief Executive Officer and Co-Founder Johan Henrik Faber appointed Chief Technology Officer Financing led by Novo Holdings, HealthCap and RA Capital Management Advancing pipeline of bispecific and monoclonal antibodies with ... Biopharmaceuticals, Venture Capital Hemab , thrombosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 22, 2021 Category: Pharmaceuticals Source Type: news

FDA Grants Breakthrough Designation to Synapse Biomedical's TransAeris(R) System
OBERLIN, Ohio, July 21, 2021 -- (Healthcare Sales & Marketing Network) -- Synapse Biomedical, Inc®. (www.synapsebiomedical.com) announced today that the FDA has granted Breakthrough Therapy Device designation to TransAeris®, a temporary percutaneo... Devices, FDA Synapse Biomedical, TransAeris, diaphragm stimulator, mechanical ventilator (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 21, 2021 Category: Pharmaceuticals Source Type: news

Corium Launches Innovative ADHD Treatment AZSTARYS(TM) (serdexmethylphenidate and dexmethylphenidate) in the U.S. for Patients Age 6 Years and Older
AZSTARYS is the First and Only Product Containing Prodrug of Dexmethylphenidate Unique formulation provides rapid and extended duration symptom control BOSTON, July 21, 2021 -- (Healthcare Sales & Marketing Network) -- Corium, Inc., a commercial-sta... Biopharmaceutical, Neurology, Product Launch Corium Inc, AZSTARYS, ADHD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 21, 2021 Category: Pharmaceuticals Source Type: news

Study shows Smith and Nephew's REGENETEN(TM) Bioinductive Implant sets new standard of recovery for partial-thickness rotator cuff tears
LONDON, July 21, 2021 -- (Healthcare Sales & Marketing Network) -- Smith & Nephew (LSE:SN,NYSE:SNN), the global medical technology business, today announces study results showing patients treated with just its REGENETEN Bioinductive Implant for partial-th... Devices, Orthopaedic Smith & Nephew, REGENETEN Bioinductive Implant, rotator cuff tear (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 21, 2021 Category: Pharmaceuticals Source Type: news

PathogenDx Receives CE-IVD Mark for Its Microarray-Based DetectX-Rv Test for COVID-19
The low-cost, high-throughput test will now be available for qualified laboratories across the European Union SCOTTSDALE, Ariz., July 21, 2021 -- (Healthcare Sales & Marketing Network) -- PathogenDx, Inc., an Arizona based biotechnology company which h... Diagnostics, Regulatory PathogenDx, COVID-19 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 21, 2021 Category: Pharmaceuticals Source Type: news

Coave Therapeutics Closes €33 million ($39 million) Series B Financing to Develop its Gene Therapy Pipeline and Next-Generation Vectors based on its AAV-Ligand Conjugate Platform
Coave Therapeutics is the new name for Horama and reflects its new emphasis on AAV-Ligand Conjugate based vectors for CNS diseases alongside Ocular diseases Funding led by Seroba Life Sciences and supported by Théa Open Innovation, eureKARE and e... Biopharmaceuticals, Venture Capital Coave Therapeutics, gene therapy, AAV-Ligand Conjugate, ALIGATER (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 21, 2021 Category: Pharmaceuticals Source Type: news

First Light Diagnostics Receives FDA Clearance for its Rapid Clostridiodes difficile Test on the MultiPath(R) Analyzer
First FDA cleared product based on the Company's proprietary MultiPath technology CHELMSFORD, Mass., July 20, 2021 -- (Healthcare Sales & Marketing Network) -- First Light Diagnostics is developing and commercializing breakthrough automated diagnostic ... Diagnostics, FDA First Light Diagnostics, SensiTox, C. difficile test, Clostridium difficile (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 20, 2021 Category: Pharmaceuticals Source Type: news

Alma, a Sisram Medical Company, Announces FDA Clearance and the U.S. Launch of Alma Hybrid(TM)
BUFFALO GROVE, Ill., July 20, 2021 -- (Healthcare Sales & Marketing Network) -- Alma, a global leader in the energy-based medical and aesthetic solutions industry announced the U.S. Food and Drug Administration 510(k) clearance of Alma Hybrid™, the first ... Devices, Dermatology, FDA, Product Launch Alma Lasers, Alma Hybrid, laser, skin resurfacing (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 20, 2021 Category: Pharmaceuticals Source Type: news

Pharming signs agreement with NewBridge Pharmaceuticals for the commercialization of RUCONEST(R) in the Middle East and North Africa
LEIDEN, Netherlands, July 20, 2021 -- (Healthcare Sales & Marketing Network) -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces it has entered into an exclusive licence agreement w... Biopharmaceuticals, Licensing, Distribution Pharming Group, NewBridge Pharmaceuticals, RUCONEST, hereditary angioedema (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 20, 2021 Category: Pharmaceuticals Source Type: news

Nektar Appoints Dimitry S.A. Nuyten, M.D., Ph.D., as Senior Vice President and Chief Medical Officer
SAN FRANCISCO, July 19, 2021 -- (Healthcare Sales & Marketing Network) -- Nektar Therapeutics (Nasdaq: NKTR) announced today that it has appointed Dimitry S.A. Nuyten, M.D., Ph.D., as Senior Vice President and Chief Medical Officer (CMO). In his role as C... Biopharmaceuticals, Personnel Nektar Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 19, 2021 Category: Pharmaceuticals Source Type: news

BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson's Disease
CAMBRIDGE, Mass., July 19, 2021 -- (Healthcare Sales & Marketing Network) -- BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly owned subsidiary of Bayer AG, announced that the U.S. Food and Drug Administration (FDA) has grant... Regenerative Medicine, Neurology, FDA BlueRock Therapeutics, Bayer, Parkinson's disease, engineered cell therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 19, 2021 Category: Pharmaceuticals Source Type: news

Nevro Announces FDA Approval of its 10 kHz High Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated with Painful Diabetic Neuropathy (PDN)
HFX™ for PDN Now the Only Spinal Cord Stimulation System Approved by FDA to Treat PDN¹ Company Will Immediately Initiate Commercial Launch Activities in the U.S. Company Announces Preliminary, Unaudited Second Quarter 2021 Revenue of Approximate... Devices, Neurology, FDA, Product Launch Nevro Corp, Senza , diabetic neuropathy, spinal cord stimulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 19, 2021 Category: Pharmaceuticals Source Type: news

Sandoz launches first generic high dose intravenous iron, Ferumoxytol Injection, to treat US patients with iron deficiency anemia
Patients with iron deficiency anemia in a hospital or clinic setting now have access to an important IV iron medicine at a more affordable price Iron deficiency anemia occurs when there is a lower than normal number of oxygen-carrying red blood cells be... Biopharmaceuticals, Generics, Product Launch Sandoz, Novartis, Ferumoxytol, iron deficiency (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 16, 2021 Category: Pharmaceuticals Source Type: news

Aeglea BioTherapeutics Appoints Jim Kastenmayer as General Counsel
AUSTIN, Texas, July 15, 2021 -- (Healthcare Sales & Marketing Network) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare metaboli... Biopharmaceuticals, Personnel Aeglea BioTherapeutics, pegzilarginase, Arginase 1 Deficiency (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 15, 2021 Category: Pharmaceuticals Source Type: news

iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients
World-leading surgeons to join iSTAR Medical's STAR-V study WAVRE, Belgium, July 15, 2021 -- (Healthcare Sales & Marketing Network) -- iSTAR Medical, a med-tech company developing minimally-invasive implants for glaucoma surgery (MIGS), announced today... Devices, Ophthalmology, FDA iSTAR Medical, micro-invasive glaucoma surgery, MINIject , glaucoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 15, 2021 Category: Pharmaceuticals Source Type: news

First in Human Procedure with Vessi Medical's Cryotherapy System for Bladder Cancer
MISGAV, Israel, July 14, 2021 -- (Healthcare Sales & Marketing Network) -- Vessi Medical ("Vessi"), announced that it successfully completed a first-in-human case with its minimally invasive cryoablation solution for superficial bladder cancer ... Devices, Urology, Oncology Vessi Medical, cryoablation, bladder cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 14, 2021 Category: Pharmaceuticals Source Type: news

Terumo Introduces New AZUR(TM) Vascular Plug and PG Pro(TM) Peripheral Microcatheter Embolization System
Represents the next generation technology for peripheral vascular embolization SOMERSET, N.J., July 14, 2021 -- (Healthcare Sales & Marketing Network) -- Terumo Medical Corporation (TMC) has announced today the introduction of its AZUR™ Vascular Plug, ... Devices, Interventional, Product Launch Terumo Medical, AZUR , Vascular Plug, embolization, embolotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 14, 2021 Category: Pharmaceuticals Source Type: news

First Five Patients Successfully Treated with atHeart Medical's Novel reSept(TM) Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial
The first occluder with a metal-free, bioresorbable frame for the treatment of patients with clinically significant, isolated ASDs BAAR, Switzerland and MOUNTAIN VIEW, Calif., July 14, 2021 -- (Healthcare Sales & Marketing Network) -- atHeart Medical, ... Devices, Interventional, Cardiology atHeart Medical, reSept ASD Occluder, atrial septal defect (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 14, 2021 Category: Pharmaceuticals Source Type: news

Lilly Announces Acquisition of Protomer Technologies
INDIANAPOLIS, July 14, 2021 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) today announced the acquisition of Protomer Technologies ("Protomer"), a private biotech company. Protomer's proprietary peptide- and prot... Biopharmaceuticals, Mergers & Acquisitions Eli Lilly, Protomer Technologies (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 14, 2021 Category: Pharmaceuticals Source Type: news

Regulatory Affairs Expert Ana Sousa Joins Aspen Neuroscience as Senior Vice President
SAN DIEGO, July 13, 2021 -- (Healthcare Sales & Marketing Network) -- Aspen Neuroscience, Inc., a private biotechnology company developing the first autologous neuron replacement therapies to treat Parkinson's disease (PD), announced today that Ana Sousa ... Regenerative Medicine, Neurology, Personnel Aspen Neuroscience, Parkinson, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 13, 2021 Category: Pharmaceuticals Source Type: news

Stryker announces the FDA clearance of the first biodegradable subacromial balloon spacer, filling a gap in the shoulder continuum of care
The InSpace balloon implant is a breakthrough solution for arthroscopic treatment of massive irreparable rotator cuff tears that is efficient and provides sustained patient improvements (NCT02493660) KALAMAZOO, Mich., July 13, 2021 -- (Healthcare Sales ... Devices, Orthopaedic, FDA Stryker, InSpace balloon, subacromial tissue spacer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 13, 2021 Category: Pharmaceuticals Source Type: news

Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
Company is pioneering true "search and replace" gene editing to address the fundamental genetic causes of disease, restore normal gene function, and potentially provide patients with long-lasting cures Company led by Chief Executive Officer Ke... Biopharmaceuticals, Venture Capital Prime Medicine, Prime Editing, gene editing (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 13, 2021 Category: Pharmaceuticals Source Type: news

Janssen Announces U.S. FDA Approval of DARZALEX FASPRO(R) (daratumumab and hyaluronidase-fihj) in Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse
DARZALEX FASPRO® is now the first and only subcutaneous anti-CD38 monoclonal antibody approved in combination with pomalidomide and dexamethasone HORSHAM, Pa., July 12, 2021 -- (Healthcare Sales & Marketing Network) -- The Janssen Pharmaceutical Co... Biopharmaceuticals, Oncology, FDA Janssen Pharmaceutical, Johnson & Johnson, DARZALEX FASPRO®, daratumumab (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 12, 2021 Category: Pharmaceuticals Source Type: news

Cardiff Oncology Announces the Appointments of Katherine L. Ruffner, M.D., as Chief Medical Officer and James E. Levine as Chief Financial Officer
Dr. Ruffner is a US-trained hematologist/oncologist with over 25 years of clinical care, oncology biotechnology and pharmaceutical drug development experience Mr. Levine has over 20 years of corporate and investment banking experience in the biotechnolo... Biopharmaceuticals, Oncology, Personnel Cardiff Oncology, Onvansertib, Colorectal Cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 12, 2021 Category: Pharmaceuticals Source Type: news

FDA Approves Expanded Sterilization and Disinfectant Methods for the LUMINELLE(R) DTx System
Offers Extended Hospital Utilization and Enhanced Patient Safety RALEIGH, N.C., July 12, 2021 -- (Healthcare Sales & Marketing Network) -- UVision360, Inc., an innovative medical device company, announces today that the U.S. Food and Drug Administratio... Devices, FDA UVision360, LUMINELLE 360° Bx, LUMINELLE DTx (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 12, 2021 Category: Pharmaceuticals Source Type: news

BD Announces Two Future Directors for Diabetes Care Spinoff Company
David F. Melcher to be non-executive chair; Claire Pomeroy, MD, MBA, to be a director FRANKLIN LAKES, N.J., July 12, 2021 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology c... Devices, Endocrinology, Personnel BD , Diabetes Care (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 12, 2021 Category: Pharmaceuticals Source Type: news

Hummingbird Bioscience and MD Anderson Announce Strategic Research Collaboration To Advance Innovative Immunotherapies
Multi-year collaboration will investigate and evaluate Hummingbird's HMBD-002 VISTA antagonist antibody HOUSTON and SINGAPORE, July 12, 2021 -- (Healthcare Sales & Marketing Network) -- Hummingbird Bioscience, an innovative clinical-stage biotech compa... Biopharmaceuticals, Oncology Hummingbird Bioscience, Rational Antibody Discovery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 12, 2021 Category: Pharmaceuticals Source Type: news

Single Pass Closes Seed Funding Round
LAKE FOREST, Calif., July 9, 2021 -- (Healthcare Sales & Marketing Network) -- Bill Colone, CEO, announced today the closing of the seed financing round for Single Pass, Inc. (www.singlepass.co). Single Pass has developed the world's first disposable bipo... Devices, Surgery, Venture Capital Single Pass Inc, disposable bipolar electrocautery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 9, 2021 Category: Pharmaceuticals Source Type: news

Elevar Therapeutics Announces New Appointments to Strengthen its Executive and Senior Leadership Teams
Company Appoints Three Experienced Industry Leaders Across Medical, Regulatory and Quality Functions SALT LAKE CITY, July 8, 2021 -- (Healthcare Sales & Marketing Network) -- Elevar Therapeutics, Inc. ("Elevar"), a fully integrated biopharmac... Biopharmaceutical, Personnel Elevar Therapeutics, rivoceranib, apatinib, paclitaxel (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 8, 2021 Category: Pharmaceuticals Source Type: news

Medline, RenalSense Partner to Offer UO Monitoring System
BROOKLINE, Mass., July 8, 2021 -- (Healthcare Sales & Marketing Network) -- Medline Industries, Inc., a leading global healthcare manufacturer and distributor, and RenalSense Ltd., a privately-held medical device company and developer of Clarity RMS™, tod... Devices, Monitoring, Distribution RenalSense, Medline Industries, Clarity RMS (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 8, 2021 Category: Pharmaceuticals Source Type: news

Theolytics expands Series A financing and welcomes M Ventures as a new investor
Theolytics is harnessing viruses to combat cancer: transforming patients' lives; through world leading science; with a great team OXFORD, England, July 8, 2021 -- (Healthcare Sales & Marketing Network) -- M Ventures – the strategic venture capital arm ... Biopharmaceuticals, Venture Capital Theolytics, oncolytic virus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 8, 2021 Category: Pharmaceuticals Source Type: news

Hyalex Orthopaedics receives FDA Breakthrough Device Designation for novel HYALEX(R) Cartilage System
LEXINGTON, Mass., July 7, 2021 -- (Healthcare Sales & Marketing Network) -- Hyalex Orthopaedics, Inc., announced that the HYALEX® Cartilage System has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). The H... Devices, Orthopaedic, FDA Hyalex Orthopaedics, HYALEX Cartilage (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 7, 2021 Category: Pharmaceuticals Source Type: news

U.S. Food and Drug Administration Clears UVision360, Inc. Novel LUMINELLE(R) 360° Bx (Biopsy) Sheath
First and only integrated directed biopsy device when combined with the LUMINELLE DTx System RALEIGH, N.C., July 7, 2021 -- (Healthcare Sales & Marketing Network) -- UVision360, Inc., an innovative medical device company, announces today that the U.S. ... Devices, FDA UVision360, LUMINELLE 360°, LUMINELLE DTx (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 7, 2021 Category: Pharmaceuticals Source Type: news

Elekta optimizes treatment times for cancer patients via proactive service innovation
Elekta in the forefront of service innovation through first radiotherapy system availability patent STOCKHOLM, July 7, 2021 -- (Healthcare Sales & Marketing Network) -- For the last several years, Elekta (EKTA-B.ST) has invested substantially in digiti... Devices, Oncology Elekta, IntelliMax, radiotherapy, linear accelerator (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 7, 2021 Category: Pharmaceuticals Source Type: news

Delix Therapeutics Expands Executive Leadership Team
Appoints Dr. Kurt Rasmussen, Former Eli Lilly Neuroscience Leader, NIH-NIDA Head of Therapeutics Division, as Chief Scientific Officer Names Co-Founder Dr. David E. Olson as Chief Innovation Officer, Head of Scientific Advisory Board BOSTON, July 6, ... Biopharmaceuticals, Neurology, Personnel Delix Therapeutics, psychoplastogens (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 6, 2021 Category: Pharmaceuticals Source Type: news

Viracta Therapeutics Announces the Appointment of Ayman El-Guindy, Ph.D., as Chief Scientific Officer and Key Additions to Management Team
SAN DIEGO, July 6, 2021 -- (Healthcare Sales & Marketing Network) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced the appointment of Ayman El-Guindy, Ph.D., as Chief Scien... Biopharmaceuticals, Personnel Viracta Therapeutics, nanatinostat, Epstein-Barr, lymphoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 6, 2021 Category: Pharmaceuticals Source Type: news

nanoMesh(TM) LLC (a subsidiary of Exogenesis Corporation) Announces Expansion of the nanoMesh(TM) Product Line Offering to the Clinical Community
nanoMesh™, An Innovative Soft Tissue Repair Implant Possesses A Unique Nanometer-level Surface Texture BILLERICA, Mass., July 6, 2021 -- (Healthcare Sales & Marketing Network) -- nanoMesh™ LLC, a subsidiary of Exogenesis Corporation, announced today ex... Devices, Surgery, Product Launch nanoMesh, Exogenesis, hernia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 6, 2021 Category: Pharmaceuticals Source Type: news

TheraCell Exceeds Expectations With Its Limited Launch Of The TheraFuze DBF(R) Fiber Anchor(TM)
TheraCell has surpassed 200 Fiber Anchors implanted, providing surgeons a solution for improved screw fixation LOS ANGELES, July 6, 2021 -- (Healthcare Sales & Marketing Network) -- TheraCell Inc., a leading allograft solution company, today announced ... Devices, Orthopaedic, Product Launch TheraCell, TheraFuze, Fiber Anchor, demineralized bone fiber, screw anchor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 6, 2021 Category: Pharmaceuticals Source Type: news

Transine Therapeutics Appoints Industry Veteran Jan Thirkettle Ph.D. as CEO
Dr Thirkettle is a seasoned life sciences executive with deep experience and a proven track record in building successful novel platforms CAMBRIDGE, England, July 5, 2021 -- (Healthcare Sales & Marketing Network) -- Transine Therapeutics, a biotechnolo... Biopharmaceuticals, Personnel Transine Therapeutics, SINEUP, RNA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 5, 2021 Category: Pharmaceuticals Source Type: news

SonoScape obtains CE Mark for its linear array echoendoscope EG-UC5T
SHENZHEN, China, July 2, 2021 -- (Healthcare Sales & Marketing Network) -- On April 30th, SonoScape received the CE-marking, the product's "Passport to Europe", for its linear-array echoendoscope EG-UC5T. This further expands SonoScape's endosco... Devices, Regulatory SonoScape Medical, echoendoscope, EG-UC5T, endoscopic ultrasound (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 2, 2021 Category: Pharmaceuticals Source Type: news

Sirnaomics Secures $105 Million in Series E Financing
Proceeds to Fund Development of Novel RNAi Therapeutics for Cancers, Viral Infections, Fibrosis, and Metabolic Diseases GAITHERSBURG, Md. and SUZHOU BIOBAY, China, July 1, 2021 -- (Healthcare Sales & Marketing Network) -- Sirnaomics Ltd., a leading bio... Biopharmaceuticals, Venture Capital Sirnaomics, RNAi therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 1, 2021 Category: Pharmaceuticals Source Type: news

Heron Therapeutics Announces U.S. Commercial Launch and Availability of ZYNRELEF(TM) for the Management of Postoperative Pain for up to 72 Hours
ZYNRELEF, the first and only extended-release local anesthetic, is now available in distribution channels Heron has deployed new acute care sales representatives across the U.S. SAN DIEGO, July 1, 2021 -- (Healthcare Sales & Marketing Network) -- He... Biopharmaceuticals, Drug Delivery, Product Launch Heron Therapeutics, ZYNRELEF, bupivacaine, meloxicam (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 1, 2021 Category: Pharmaceuticals Source Type: news

Windtree Appoints Diane Carman, Esq. as Senior Vice President and General Counsel
WARRINGTON, Pa., July 1, 2021 -- (Healthcare Sales & Marketing Network) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmona... Biopharmaceuticals, Personnel Windtree Therapeutics, istaroxime , AEROSURF (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 1, 2021 Category: Pharmaceuticals Source Type: news

Targovax ASA appoints Dr Lone Ottesen as Chief Development Officer
OSLO, Norway, July 1, 2021 -- (Healthcare Sales & Marketing Network) -- Targovax ASA (OSE: TRVX) announces the appointment of Dr Lone Ottesen, MD, PhD as Chief Development Officer (CDO). She will take a leading role in driving the clinical programs forwar... Biopharmaceuticals, Oncology, Personnel Targovax (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 1, 2021 Category: Pharmaceuticals Source Type: news

Mitsubishi Tanabe Pharma America Announces EXSERVAN(TM) (riluzole) is Now Available in the U.S. for the Treatment of ALS
New Innovative Orally Dissolving Film Designed to Help Meet the Needs of ALS Patients Who Have Difficulty Swallowing Some Medications JERSEY CITY, N.J., June 30, 2021 -- (Healthcare Sales & Marketing Network) -- Mitsubishi Tanabe Pharma America, Inc. (... Biopharmaceuticals, Neurology, Product Launch Mitsubishi Tanabe Pharma, EXSERVAN, riluzole, amyotrophic lateral sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 30, 2021 Category: Pharmaceuticals Source Type: news

Abbott's XIENCE Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk Patients
New labeling approval for Abbott's XIENCE™ stent builds on a legacy of safety and allows for one-month (as short as 28 days) dual anti-platelet therapy (DAPT) for patients at high bleeding risk (HBR) The new XIENCE Skypoint™ stent received FDA approval ... Devices, Interventional, Cardiology, FDA Abbott, XIENCE, stent, dual anti-platelet therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 30, 2021 Category: Pharmaceuticals Source Type: news